Colorimetric assay detects uric acid with 0.25 μM limit in human serum, suggesting scalability for point-of-care testing.
The development of enzyme-free uric acid (UA) detection methods remains challenging due to cost, stability, and sensitivity limitations. Here, we report a uricase-free colorimetric biosensor using cobalt-1,3,5-benzene tricarboxylate metal-organic frameworks (CoBTC MOFs) with intrinsic peroxidase-like activity. CoBTC catalyzes the oxidation of TMB by conducting H₂O₂ to blue oxTMB, while UA reduces oxTMB to colorless TMB, allowing for the quantification of UA via absorbance changes. This biosensor achieved a detection limit of 0.25 μM and a linear range of 0.4-180 μM, outperforming many uricase-dependent assays. Clinical validation with human serum (recovery: 98-103%, RSD < 3%) confirmed the resistance to matrix effects. This work provides a scalable and low-cost alternative for point-of-care UA monitoring in diagnostic settings.
No takes yet. Share an insight, caveat, or question.
Mohammad Hossein Vaziri (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: